LONDON, June 20, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Although our release this morning mentioned last week's Supreme Court decision, we erroneously included Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) as being in the subsector impacted by the Supreme Court's decision regarding human gene patents. Peregrine has no human gene patents, and is therefore not affected by this decision.
Clarification of Industry Comments
Readers are advised that comments made about industries as a whole are meant to provide a macro-economic view of the industry and may not affect all companies within each sector or subsector equally, proportionally or even similarly. Depending on the specific context and factors unique to each individual situation, some companies may even observe inverse effects to the industry or market as a whole.
Today's Market Conditions
We would also like to remind readers; shares in almost every industry today and yesterday are tracking losses in the broader market, which are falling sharply as the market further digests comments from Federal Reserve Chairman Ben Bernanke on Wednesday and to a smaller extent, news of China's worsening cash crunch.
Not Financial Advice
Remember, information we provide is just that, information and represents our opinion only. We provide information on a best efforts basis, but this does not replace your financial advisor or supplementary due diligence. For more information on our compliance and research procedures, please refer to our disclaimer below.
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE AAA Research Reports